课题基金 / 基金详情

Investigation of the interplay between metabolic and epigenetic alterations dictating therapeutic resistance in basal breast tumours.

Investigation of the interplay between metabolic and epigenetic alterations dictating therapeutic resistance in basal breast tumours.
研究代谢和表观遗传改变之间的相互作用决定基底乳腺肿瘤的治疗耐药性。
批准号:
301025
负责人:
Deblois Genevieve
金额:
$9.83万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-11-01 至 2016-11-01

项目摘要

项目成果

Deblois Genevieve的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer is the most common and second deadliest cancer amongst women in North America. The advent of targeted therapy to treat women with breast cancer has contributed to improve the 5-year survival rate of this disease. However, resistance to thera
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the metabolic determinants of triple-negative breast cancer progression through chromatin dependencies
  • 批准号:
    448075
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Deblois Genevieve
  • 依托单位:
Prize - 202109PJT - Investigating the metabolic determinants of triple-negative breast cancer progression through chromatin dependencies
  • 批准号:
    460119
  • 项目类别:
    Operating Grants
  • 资助金额:
    $1.82万
  • 财政年份:
    2021
  • 负责人:
    Deblois Genevieve
  • 依托单位:
Investigating the metabolic determinants of triple-negative breast cancer progression through chromatin dependencies
  • 批准号:
    452533
  • 项目类别:
    Operating Grants
  • 资助金额:
    $45.14万
  • 财政年份:
    2021
  • 负责人:
    Deblois Genevieve
  • 依托单位:
Investigating the metabolic determinants of triple-negative breast cancer progression through chromatin dependencies
  • 批准号:
    431824
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2020
  • 负责人:
    Deblois Genevieve
  • 依托单位:
海外基金